CVP alternating with fludarabine (CVP/F) chemotherapy prior to idiotype vaccination for follicular lymphoma (FL)
Weiyun Z. Ai(City College of San Francisco), Sandra J. Horning(Stanford University), Behnaz Taidi, John M. Timmerman(Sheba Medical Center), Debra K. Czerwinski(Stanford University), Frank J. Hsu(Sanofi (France)), Raphaël Lévy(Inserm)
Cited by 0
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
|The Oncologist|2000|1.3k